[PDF][PDF] Partial EMT takes the lead in cancer metastasis
J Haerinck, G Berx - Developmental Cell, 2021 - cell.com
Developmental Cell, 2021•cell.com
In this issue of Developmental Cell, Lüönd et al. developed a tracing system, using the
uncharacterized early epithelial-mesenchymal transition (EMT)-marker Tenascin C, to
monitor cells undergoing partial EMT during malignant mammary cancer progression. They
find that partial, but not full, EMT contributes to metastasis and that full EMT contributes to
chemoresistance.
uncharacterized early epithelial-mesenchymal transition (EMT)-marker Tenascin C, to
monitor cells undergoing partial EMT during malignant mammary cancer progression. They
find that partial, but not full, EMT contributes to metastasis and that full EMT contributes to
chemoresistance.
In this issue of Developmental Cell, Lüönd et al. developed a tracing system, using the uncharacterized early epithelial-mesenchymal transition (EMT)-marker Tenascin C, to monitor cells undergoing partial EMT during malignant mammary cancer progression. They find that partial, but not full, EMT contributes to metastasis and that full EMT contributes to chemoresistance.
cell.com
